
Immunomic Therapeutics
Rockville, MD, United States · immunomix.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Immunomic Therapeutics, Inc. is a privately held clinical-stage biotechnology company developing vaccine and immunotherapy programs using its UNITE platform. It works in oncology, animal health, infectious disease, and allergy, and is headquartered in Rockville, Maryland.
Their website has a general contact form; we send your quote request through it.
What they offer
Vaccine development using UNITE
Develops vaccines using the proprietary UNITE platform to generate broad immune responses.
Oncology immunotherapy development
Builds oncology programs using UNITE, including glioblastoma and Merkel cell carcinoma programs.
Dendritic cell therapy development
Develops dendritic cell therapy programs such as ITI-1000 for glioblastoma multiforme.
pDNA immunotherapy development
Develops off-the-shelf cancer immunotherapy programs based on plasmid DNA and the UNITE platform.
What they work on
- Modalities
- Antibody, mRNA, Cell therapy, Vaccine, Plasmid DNA
- Species and models
- autologous dendritic cells, malignant glial cells, CMV-associated antigens
- Assays and studies
- immune response generation, T cell-mediated response, antigen presentation pathway analysis
- Therapeutic areas
- oncology, glioblastoma multiforme, Merkel cell carcinoma, animal health, infectious disease, allergy
- What to send
- white blood cells removed from GBM patients for ITI-1000
- Sites
- Rockville, United States
- Address
- 15010 Broschart Road Rockville, MD 20850
Similar labs. Abnova, AGC Biologics, GenScript, JPT Peptide Technologies
Found in a contract services directory. Listing built from immunomix.com. Work here? Claim this listing.